Minichromosome maintenance-7 and geminin are reliable prognostic markers in patients with oral squamous cell carcinoma: Immunohistochemical study

Journal of Oral Pathology and Medicine

Volumn 39, Issue 4, 2010, Pages 328-334

  Tamura, Takayuki ^a   Shomori, Kohei ^a   Haruki, Tomohiro ^a   Nosaka, Kanae ^a   Hamamoto, Yuki ^a   Shiomi, Tatsushi ^a   Ryoke, Kazuo ^a   Ito, Hisao ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Dysplasia; Geminin; Immunohistochemistry; Minichromosome maintenance 7; Oral squamous cell carcinoma; Prognosis; Western blot

Indexed keywords

GEMININ; KI 67 ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN 7;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; EPITHELIUM DYSPLASIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; MOUTH CARCINOMA; MOUTH MUCOSA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR VOLUME;

AGED; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHEMOTHERAPY, ADJUVANT; DNA REPLICATION; DNA-BINDING PROTEINS; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; NUCLEAR PROTEINS; PRECANCEROUS CONDITIONS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 77950475618     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00861.x     Document Type: Article

References (38)

1. Momose F, Araida T, Negishi A, Ichijo H, Shioda S, Sasaki S. Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas. J Oral Pathol Med 1989 18 : 391 395. (Pubitemid 20001923)
2. Sakai E, Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene 1992 7 : 927 933.
3. Parken DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988 41 : 184 197. (Pubitemid 18061141)
4. Day GL, Blot WJ. Second primary tumors in patients with oral cancer. Cancer 1992 70 : 14 9.
5. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the USA: a site-specific analysis of the SEER database. Int J Cancer 2004 114 : 806 816.
6. Hiratuka H, Miyakawa A, Nakamori K, Kido Y, Sunakawa H, Kohama G. Multivariate analysis of occult lymph node metastasis as a prognostic indicator for patients with squamous cell carcinoma of the oral cavity. Cancer 1997 80 : 351 356. (Pubitemid 27323403)
7. Take Y, Umeda M, Teranobu O, Shimada K. Lymph node metastases in hamster tongue cancer induced with 9,10-dimethyl-1,2-benzanthracene: association between histological findings and the incidence of neck metastases, and the clinical implications for patients with tongue cancer. Br J Oral Maxillofac Surg 1999 37 : 29 36. (Pubitemid 29095043)
8. Robert MB, Adel K.El-N, Ya-Yen L, et al. Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? Head Neck 1998 20 : 138 144.
9. Szelachowska J, Dziegiel P, Jelen-Krzeszewska J, et al. Mcm-2 protein expression predicts prognosis better than Ki-67 antigen in oral cavity squamocellular carcinoma. Anticancer Res 2006 26 : 2473 2478. (Pubitemid 43980220)
10. Lo Muzio L, Santarelli A, Caltabiano R, et al. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma. Hum Pathol 2005 36 : 187 194. (Pubitemid 40313576)
11. Kodani I, Osaki M, Shomori K, et al. Minichromosome maintenance 2 expression is correlated with mode of invasion and prognosis in oral squamous cell carcinomas. J Oral Pathol Med 2003 32 : 468 474. (Pubitemid 37039921)
12. Chong JP, Mahbubani HM, Khoo CY, Blow JJ. Purification of an MCM-containing complex as a component of the DNA replication licensing system. Nature 1995 375 : 418 421.
13. Dimitrova DS, Prokhorova TA, Blow JJ, Todorov IT, Gilbert DM. Mammalian nuclei become licensed for DNA replication during late telophase. J Cell Sci 2002 115 : 51 9.
14. Blow JJ, Hodgson B. Replication licensing-defining the proliferative state? Trends Cell Biol 2002 12 : 72 8.
15. Noton E, Diffley JF. CDK inactivation is the only essential function of the APC/C and the mitotic exit network proteins for origin resetting during mitosis. Mol Cell 2000 5 : 85 95. (Pubitemid 30105438)
16. Wohlschlegel JA, Dwyer BT, Dhar SK, Cvetic C, Walter JC, Dutta A. Inhibition of eukaryotic DNA replication by geminin binding to Cdt1. Science 2000 290 : 2309 2312. (Pubitemid 32041574)
17. Ishimi Y. A DNA helicase activity is associated with an MCM4, -6, and -7 protein complex. J Biol Chem 1997 272 : 24508 24513. (Pubitemid 27418662)
18. Nishihara K, Shomori K, Fujioka S, et al. Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance. Int J Oncol 2008 33 : 245 251.
19. Fujioka S, Shomori K, Nishihara K, et al. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): prognostic implication. Lung Cancer 2009 65 : 223 229.
20. Ren B, Yu G, Tseng GC, et al. MCM7 amplification and overexpression are associated with prostate cancer progression. Oncogene 2006 25 : 1090 1098. (Pubitemid 43277016)
21. Brake T, Connor JP, Petereit DG, Lambert PF. Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer. Cancer Res 2003 63 : 8173 8180. (Pubitemid 37549465)
22. McGarry TJ, Kirschner MW. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 1998 93 : 1043 1053.
23. Gonzalez MA, Tachibana KE, Chin SF, et al. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J Pathol 2004 204 : 121 130.
24. Dudderidge TJ, Stoeber K, Loddo M, et al. MCM2, geminin, and KI-67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin Cancer Res 2005 11 : 2510 2517. (Pubitemid 40569447)
25. Nishihara K, Shomori K, Tamura T, Fujioka S, Ogawa T, Ito H. Immunohistochemical expression of geminin in colorectal cancer: Implication of prognostic significance. Oncol Rep 2009 21 : 1189 1195.
26. Sobin LH, Fleming ID. TNM classification of malignant tumors, 5th edn. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997 80 : 1803 1804.
27. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I. Histological Typing of Cancer and Precancer of the Oral Mucosa, 2nd edn.
28. Jakobsson PA, Eneroth CM, Killander D, Moberger G, Martensson B. Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys Biol 1973 12 : 1 8.
29. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981 29 : 577 580. (Pubitemid 11147380)
30. Scott IS, Odell E, Chatrath P, et al. A minimally invasive immunocytochemical approach to early detection of oral squamous cell carcinoma and dysplasia. Br J Cancer 2006 94 : 1170 1175.
31. Feng CJ, Li HJ, Li JN, Lu YJ, Liao GQ. Expression of MCM7 and CDC6 in oral squamous cell carcinoma and pre-cancerous lesions. Anticancer Res 2008 28 : 3763 3769.
32. Torres-Rendon A, Roy S, Craig GT, Speight PM. Expression of MCM2, geminin and Ki-67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas. Br J Cancer 2009 100 : 1128 1134.
33. Tokuyasu N, Shomori K, Nishihara K, et al. Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance. Gastric Cancer 2008 11 : 37 46. (Pubitemid 351464483)
34. Eward KL, Obermann EC, Shreeram S, et al. DNA replication licensing in somatic and germ cells. J Cell Sci 2004 117 : 5875 5886. (Pubitemid 40123953)
35. Stoeber K, Tlsty TD, Happerfield L, et al. DNA replication licensing and human cell proliferation. J Cell Sci 2001 114 : 2027 2041. (Pubitemid 32586628)
36. Li SS, Xue WC, Khoo US, et al. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis. Histopathology 2005 46 : 307 313.
37. Shrestha P, Saito T, Hama S, et al. Geminin: a good prognostic factor in high-grade astrocytic brain tumors. Cancer 2007 109 : 949 956. (Pubitemid 46343481)
38. Montanari M, Boninsegna A, Faraglia B, et al. Increased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumors. J Cell Physiol 2005 202 : 215 222. (Pubitemid 39603378)